BusinessAchillion Reports First Quarter 2017 Financial Results and Provides Update on Clinical ProgramsBy Nasdaq OMXMay 4, 2017, 10:05 AM UTC
BusinessAgile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and GynecologistsBy Nasdaq OMXMay 3, 2017, 8:15 PM UTC
BusinessAbeona Therapeutics Provides Update on EB-101 Gene Therapy for Severe Form of Epidermolysis Bullosa from the Society for Investigative Dermatology ConferenceBy Nasdaq OMXMay 2, 2017, 12:05 PM UTC
BusinessPhase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases With Data Showing Summit’s Ridinilazole Achieved Statistical Superiority over Vancomycin in the Treatment of C. Difficile InfectionBy Nasdaq OMXApr 28, 2017, 10:30 PM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:02 AM UTC
